Article
Dysregulation of antiviral helicase pathways in systemic lupus erythematosus
25 Nov 2014
Abstract excerpt
In the autoimmune disease systemic lupus erythematosus (SLE), our normal antiviral defenses are inappropriately activated, resulting in over-activity of the type I interferon (IFN) pathway. This increased activity of the type I IFN pathway is an important primary pathogenic factor in the disease. Emerging evidence has implicated the antiviral helicases in this process. The antiviral helicases normally function as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
